Market Cap 60.82B
Revenue (ttm) 2.25B
Net Income (ttm) -278.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 394.29
Profit Margin -12.37%
Debt to Equity Ratio 0.00
Volume 771,300
Avg Vol 1,085,448
Day's Range N/A - N/A
Shares Out 131.08M
Stochastic %K 17%
Beta 0.36
Analysts Strong Sell
Price Target $483.00

Company Profile

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 551 8200
Fax: 617 551 8101
Address:
675 West Kendall Street, Henri A. Termeer Square, Cambridge, United States
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:05 PM
$ALKT $ALL $ALLY $ALMU $ALNY 🔥 Cycle Trading Signal plugged into AI 🔥 list 10/10 to 10/24 results
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 3:16 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $464.08 Contracts: $ALNY January 15, 2027 $470 Calls Scale in: $90.82- $111.00 Scale out: $141.27-$181.64 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
smartkarma
smartkarma Oct. 24 at 1:34 AM
$ALNY | Nasdaq100 Dec2025 Forecast (Part 2): ALNY at the Top; GFS at the Bottom; Spinoffs Pending "ALNY leads additions while GFS tops deletions for December 2025. VSNT and SOLS are expected to be removed within days of their respective spinoffs, beginning with SOLS on 30 October." - Dimitris Ioannidis (ORTEX) Read more: https://www.smartkarma.com/insights/nasdaq100-dec2025-forecast-part-2-alny-at-the-top-gfs-at-the-bottom-spinoffs-pending
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 23 at 6:11 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 3:54 AM
Enter: $ALNY NOV 21 2025 $470 CALLS Buy in Price: $25.65 - $26.40 Take Profit: $36.68 Stop Bleeding: $22.57 ROI Potential: 43% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 22 at 5:51 PM
$ALNY Share Price: $462.18 Contract Selected: Mar 20, 2026 $460 Calls Buy Zone: $47.26 – $58.38 Target Zone: $79.36 – $96.99 Potential Upside: 59% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 3:07 AM
Enter: $ALNY NOV 21 2025 $480 CALLS Buy in Price: $25.70 - $27.40 Take Profit: $51.91 Stop Bleeding: $22.62 ROI Potential: 102% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 1:35 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $481.67 Contracts: $ALNY January 15, 2027 $500 Calls Scale in: $73.71- $90.09 Scale out: $114.66-$147.42 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:27 AM
Enter: $ALNY NOV 21 2025 $490 CALLS Buy in Price: $26.96 - $28.80 Take Profit: $48.80 Stop Bleeding: $23.72 ROI Potential: 81% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 12:23 AM
Enter: $ALNY NOV 21 2025 $490 CALLS Buy in Price: $26.96 - $28.80 Take Profit: $51.76 Stop Bleeding: $23.72 ROI Potential: 92% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on ALNY
mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

BNTX DHR GRAL ILMN IONS MRNA RGEN


Scenic Enters License and Research Agreement with Alnylam

Aug 26, 2025, 5:00 AM EDT - 2 months ago

Scenic Enters License and Research Agreement with Alnylam


Alnylam: Amvuttra Is Just Getting Started

Jul 31, 2025, 3:13 PM EDT - 3 months ago

Alnylam: Amvuttra Is Just Getting Started


Alnylam Pharma Stock Outlook: Is ALNY Topping Out?

Jul 1, 2025, 9:06 AM EDT - 4 months ago

Alnylam Pharma Stock Outlook: Is ALNY Topping Out?


Alnylam Pharmaceuticals Names Garg R&D Chief

Jun 18, 2025, 12:04 PM EDT - 4 months ago

Alnylam Pharmaceuticals Names Garg R&D Chief


Alnylam Issues 2024 Corporate Responsibility Report

May 20, 2025, 9:00 AM EDT - 5 months ago

Alnylam Issues 2024 Corporate Responsibility Report


Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster

Mar 21, 2025, 5:37 PM EDT - 7 months ago

Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster


Alnylam shares rise on expanded heart drug approval

Mar 21, 2025, 7:34 AM EDT - 7 months ago

Alnylam shares rise on expanded heart drug approval


BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:05 PM
$ALKT $ALL $ALLY $ALMU $ALNY 🔥 Cycle Trading Signal plugged into AI 🔥 list 10/10 to 10/24 results
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 3:16 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $464.08 Contracts: $ALNY January 15, 2027 $470 Calls Scale in: $90.82- $111.00 Scale out: $141.27-$181.64 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
smartkarma
smartkarma Oct. 24 at 1:34 AM
$ALNY | Nasdaq100 Dec2025 Forecast (Part 2): ALNY at the Top; GFS at the Bottom; Spinoffs Pending "ALNY leads additions while GFS tops deletions for December 2025. VSNT and SOLS are expected to be removed within days of their respective spinoffs, beginning with SOLS on 30 October." - Dimitris Ioannidis (ORTEX) Read more: https://www.smartkarma.com/insights/nasdaq100-dec2025-forecast-part-2-alny-at-the-top-gfs-at-the-bottom-spinoffs-pending
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 23 at 6:11 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 3:54 AM
Enter: $ALNY NOV 21 2025 $470 CALLS Buy in Price: $25.65 - $26.40 Take Profit: $36.68 Stop Bleeding: $22.57 ROI Potential: 43% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 22 at 5:51 PM
$ALNY Share Price: $462.18 Contract Selected: Mar 20, 2026 $460 Calls Buy Zone: $47.26 – $58.38 Target Zone: $79.36 – $96.99 Potential Upside: 59% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 3:07 AM
Enter: $ALNY NOV 21 2025 $480 CALLS Buy in Price: $25.70 - $27.40 Take Profit: $51.91 Stop Bleeding: $22.62 ROI Potential: 102% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 1:35 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $481.67 Contracts: $ALNY January 15, 2027 $500 Calls Scale in: $73.71- $90.09 Scale out: $114.66-$147.42 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:27 AM
Enter: $ALNY NOV 21 2025 $490 CALLS Buy in Price: $26.96 - $28.80 Take Profit: $48.80 Stop Bleeding: $23.72 ROI Potential: 81% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 12:23 AM
Enter: $ALNY NOV 21 2025 $490 CALLS Buy in Price: $26.96 - $28.80 Take Profit: $51.76 Stop Bleeding: $23.72 ROI Potential: 92% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 4:50 AM
Enter: $ALNY NOV 21 2025 $490 CALLS Buy in Price: $26.96 - $31.30 Take Profit: $64.43 Stop Bleeding: $23.72 ROI Potential: 139% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 18 at 4:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $481.07 Contracts: $ALNY January 15, 2027 $500 Calls Scale in: $73.71- $90.09 Scale out: $114.66-$147.42 Can Easily Capture: 60% ROI Blended DTE: 455 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 1:47 PM
Truist Securities updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Buy, target set at 459 → 535.
1 · Reply
StockConsultant
StockConsultant Oct. 17 at 1:25 PM
$ALNY Alnylam Pharmaceuticals stock, narrow range breakout
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 16 at 10:03 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $470.27 Contracts: $ALNY January 15, 2027 $480 Calls Scale in: $76.59- $93.60 Scale out: $119.13-$153.17 Can Easily Capture: 60% ROI Blended DTE: 456 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
IsabellaDC
IsabellaDC Oct. 16 at 2:44 PM
Stocks that are at an all-time high: $MPWR $FN $ALNY $MU $GRAL and so on...
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 12:39 PM
Enter: $ALNY NOV 21 2025 $480 CALLS Buy in Price: $28.40 - $28.85 Take Profit: $57.99 Stop Bleeding: $25.39 ROI Potential: 101% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Varlamovnyse
Varlamovnyse Oct. 15 at 9:24 AM
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 6:30 AM
Enter: $ALNY NOV 21 2025 $470 CALLS Buy in Price: $32.10 - $35.72 Take Profit: $52.87 Stop Bleeding: $31.43 ROI Potential: 48% Exit Within: 1 Weeks https://moneygroup.us/alerts
0 · Reply
johnnygogogo
johnnygogogo Oct. 14 at 3:17 PM
$ALNY it’s a $475 vs. $473 Morgan sandwich. Double Morgan, hold the onions! @skeezbag
1 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 14 at 7:07 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ALNY Current Share Price: $460.46 Contracts: $ALNY January 15, 2027 $470 Calls Scale in: $47.05- $57.50 Scale out: $73.18-$94.09 Can Easily Capture: 60% ROI Blended DTE: 459 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 14 at 6:40 AM
Enter: $ALNY NOV 21 2025 $470 CALLS Buy in Price: $29.80 - $31.00 Take Profit: $69.75 Stop Bleeding: $27.28 ROI Potential: 125% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply